Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland, the platform of a leading European energy supplier and contracting specialist GETEC Group. They are the new owner and operator of the properties and infrastructure
Tags :Gregor Bühler
GAM Holding has announced the sale of its third party fund services («FMS Businesses») in Luxembourg and Switzerland to Carne Group. The announcement of the sale is a material step towards fulfilling a condition of
Siegfried and DiNAQOR entered into an agreement relating to the acquisition by Siegfried of a 95% stake in DiNAQOR DiNAMIQS, a Swiss-based biotechnology company focused on the development and manufacturing of viral vectors for cell and
Solenis has announced that it has entered into a definitive merger agreement under which Solenis will acquire Diversey in an all-cash transaction valued at an enterprise value of approximately USD 4.6 billion. Upon completion of the
The controlling shareholder of Reuge, the renowned music box producer, successfully completed the sale of a majority stake in the Reuge manufacture to the Swiss luxury watchmaker De Bethune. The independent watchmaker, known for its
Clear Channel Outdoor Holdings, a global out-of-home advertising company, announced that it has entered into a definitive agreement to sell its Swiss business to Goldbach Group, an affiliate of TX Group, for CHF 86 million. The
BRUSA HyPower, an innovative global supplier of power conversion systems for heavy-duty applications, has announced a minority investment by Bosch Rexroth, M&G Investments and Temasek. The investment aims to accelerate product development and
On January 31, 2022, FNZ, a global wealth management platform, has completed the acquisition of Appway, the leader in client onboarding and servicing for financial institutions. Homburger acted as Swiss counsel to FNZ in this transaction. The
FNZ, a global wealth management platform, has agreed to acquire Appway from its founding shareholders and Summit Partners. Appway is a provider of client onboarding and client servicing for financial institutions. The transaction is due
Kohlberg Kravis Roberts & Co (KKR), a global investment firm, and Biosynth Carbosynth, a life sciences reagents and custom synthesis and manufacturing services company, have entered into an agreement where KKR will acquire Biosynth Carbosynth
